The new antibody cancer treatment has shown promise in a trial.

Published Date: 26 Jul 2023

A new class of cancer immunotherapy has undergone its first clinical trial, with encouraging results that may help patients who are not responding to current cancer treatments.

Read Full News

Latest News

Air Pollution Linked to Reduced Midlife Cognitive Function

Everyday exposure to traffic, industry, and wildfire smoke was associated with vascular brain injury in middle age.

Perinatal Grief and Disney’s Versa: Can Films Change Care?

Spanish clinicians and grief advocates stress that compassionate communication and bereavement support shape how families process perinatal loss.

Eye Care Sees Green: Recycling Comes for Contact Lens Waste

Self-Screening Tool for AxSpA Aims to Lower Diagnostic Delay

The patient self-screening tool that was developed to help identify axial spondyloarthritis promises to cut time to diagnosis and is being evaluated in a large European cohort.

Single Bevacizumab Dose Sustains Trabeculectomy Success

A single injection of bevacizumab given during glaucoma surgery is associated with improved chances of surgical success even 3 years after the operation, a follow-up study of a clinical trial shows.

For Med Students, Finding the Right Mentor Can Be a Boost

Start with your advisors to find a mentor in your specialty or in another.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

Everyday exposure to traffic, industry, and wildfire smoke was associated with vascular brain injury in middle age.

Spanish clinicians and grief advocates stress that compassionate communication and bereavement support shape how families process perinatal loss.

The patient self-screening tool that was developed to help identify axial spondyloarthritis promises to cut time to diagnosis and is being evaluated in a large European cohort.

A single injection of bevacizumab given during glaucoma surgery is associated with improved chances of surgical success even 3 years after the operation, a follow-up study of a clinical trial shows.

Start with your advisors to find a mentor in your specialty or in another.

News All Time

IA Thrombolysis After Thrombectomy: More Uncertainty

The TECNO trial finds no clear reperfusion benefit from intra-arterial thrombolysis after thrombectomy in acute ischemic stroke, raising fresh doubts about the strategy.

Aging in Hospital Medicine: How to Retain Older Hospitalists

The schedule and demanding nature of the job make hospitalist jobs more difficult as you age. Some systems are trying to help.

Soccer-Study Warns Of Dangerous Heat At 2026 World Cup as Climate Risks Grow

Football's global players' union renewed concerns on Thursday about heat at the 2026 World Cup after scientists warned the likelihood of dangerous temperatures for players...

Is Flare Prophylaxis Always Needed When Starting Gout Drugs?

There are divided opinions over whether anti-inflammatory drugs should always be used when initiating urate-lowering therapy for gout. Would a ‘pill in the pocket’ approach be better?

CMV Infection in Early Pregnancy Tied to Autism Risk in Kids

Children with congenital cytomegalovirus infection may experience complications such as autism and hearing loss if their mothers have a first-time infection during the first trimester.

Medicine Through Film: 10 Classics for Clinicians

Ten cinematic classics trace medicine’s moral, social, and scientific dilemmas — a curated watchlist that highlights storytelling, stigma, and a call for female leads.

Corticosteroids May Raise Risk for Mortality in IPF

The use of corticosteroids is linked to a higher risk for mortality in patients with acute exacerbations of idiopathic pulmonary fibrosis.

Mollicute Screening Improves Outcomes After Lung Transplant

Donor-recipient RNA assay significantly reduced the days to diagnosis of infection.

Hung Up on Hantavirus? How to Answer If Patients Are Asking

Recent outbreak on a Dutch cruise ship poses no risk to public at large, experts say.

Could AI Copilots Reduce Clinician Documentation Time?

Ambient AI systems may reduce documentation demands and allow physicians to spend more time interacting directly with patients during their visits.

Hantavirus-hit Cruise Ship Heads to Spain After Three People Evacuated

A luxury cruise ship hit by a deadly hantavirus outbreak and marooned since Sunday off the coast of Cape Verde left for Spain on Wednesday, a Reuters witness said, after...

German Woman on Hantavirus-Hit Ship to Be Tested in Germany

A German national who had contact with an infected person onboard a cruise ship hit by hantavirus will be brought to a hospital in the German city of Duesseldorf for ⁠testing.

Hantavirus-hit Cruise Ship to Head to Spain After Permission Granted to Dock in Canary Islands

A luxury cruise ship that has been hit by an outbreak of the deadly hantavirus was preparing to travel from Cape Verde towards Europe on Wednesday after the Spanish...

COVID Tx Failed to Curb Hospitalization in High-Risk Adults

Treatment was associated with reduced viral load compared with usual care.

Convicted Former Harvard Scientist Rebuilds Brain Computer Lab in China

An American scientist convicted of lying to U.S. authorities about payments from China while he was at Harvard University has rebuilt his research lab in Shenzhen to pursue...

‘Living’ Database Tracks Psilocybin Trials for Depression

Sypres.io continuously tracks and evaluates psychedelic research, offering an up-to date view of study findings, design, and limitations.

Recommended News For You

In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.

Radioligand Therapy Set to Transform Oncology Care

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Women are more susceptible to the stress caused by inflation.

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness

Waist circumference outshines BMI as obesity-related cancer risk marker in men, but not women

Women who miss their first mammogram face higher risk of breast cancer death, study finds

Recommended Articles For You

Mechanisms, Efficacy, and Survival Outcomes in AML, Squamous Cell Carcinoma, & Non-Hodgkin Lymphoma 

Phosphate Vs. Phosphorus: What Is The Difference? 

What Is A Normal Fibrinogen Level, And How Can It Affect Your Health 

Understanding Colon Cancer: Symptoms, Causes, and Treatment Options  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

3.

Research finds stark disparities in treatment and survival time for people with pancreatic cancer

4.

Tumor characteristics found to differ for melanomas in children, teens and young adults

5.

Relationship-building key to addressing oncologist shortages in rural care

1.

Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook

2.

Colon cancer: Risk factors, warning signs and treatment options 

3.

Exploring the Latest Advances in Hodgkin's Lymphoma Treatment

4.

Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?

5.

The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

2.

Efficient Management of First line ALK-rearranged NSCLC - Part VIII

3.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

5.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot